Open access peer-reviewed chapter

Dystonia, Spasticity and Botulinum Toxin Therapy: Rationale, Evidences and Clinical Context

By Raymond L. Rosales

Submitted: February 18th 2011Reviewed: November 2nd 2011Published: March 14th 2012

DOI: 10.5772/27435

Downloaded: 2562

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Raymond L. Rosales (March 14th 2012). Dystonia, Spasticity and Botulinum Toxin Therapy: Rationale, Evidences and Clinical Context, Dystonia Raymond Rosales, IntechOpen, DOI: 10.5772/27435. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/dystonia-the-many-facets/dystonia-spasticity-and-botulinum-toxin-therapy-rationale-evidences-and-clinical-context" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2562total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Dystonia and Dopaminergic Therapy: Rationale Derived from Pediatric Neurotransmitter Diseases

By Hiroki Fujioka

Related Book

First chapter

Introductory Chapter: Botulinum Toxin Type A Therapy in Dystonia and Spasticity - What are Current Practical Applications?

By Raymond L. Rosales and Dirk Dressler

We are IntechOpen, the first native scientific publisher of Open Access books. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,350 Open Access Books

+57,400 Citations in Web of Science

+107,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us